Attached files

file filename
EX-99.2 - FORM OF COMPENSATION COMMITTEE CHARTER. - Clarus Therapeutics Holdings, Inc.fs12020ex99-2_bluewater.htm
EX-99.6 - CONSENT OF MICHAEL LERNER. - Clarus Therapeutics Holdings, Inc.fs12020ex99-6_bluewater.htm
EX-99.5 - CONSENT OF ALLAN L. SHAW. - Clarus Therapeutics Holdings, Inc.fs12020ex99-5_bluewater.htm
EX-99.4 - CONSENT OF KIM MURPHY. - Clarus Therapeutics Holdings, Inc.fs12020ex99-4_bluewater.htm
EX-99.3 - CONSENT OF JAMES SAPIRSTEIN. - Clarus Therapeutics Holdings, Inc.fs12020ex99-3_bluewater.htm
EX-99.1 - FORM OF AUDIT COMMITTEE CHARTER. - Clarus Therapeutics Holdings, Inc.fs12020ex99-1_bluewater.htm
EX-14.1 - FORM OF CODE OF ETHICS. - Clarus Therapeutics Holdings, Inc.fs12020ex14-1_bluewater.htm
EX-10.5 - SECURITIES SUBSCRIPTION AGREEMENT, DATED JUNE 30, 2020, BETWEEN THE REGISTRANT A - Clarus Therapeutics Holdings, Inc.fs12020ex10-5_bluewater.htm
EX-10.1 - PROMISSORY NOTE, DATED JUNE 30, 2020, ISSUED TO JOSEPH HERNANDEZ - Clarus Therapeutics Holdings, Inc.fs12020ex10-1_bluewater.htm
EX-3.3 - BYLAWS - Clarus Therapeutics Holdings, Inc.fs12020ex3-3_bluewater.htm
EX-3.1 - CERTIFICATE OF INCORPORATION. - Clarus Therapeutics Holdings, Inc.fs12020ex3-1_bluewater.htm
S-1 - REGISTRATION STATEMENT ON FORM S-1 - Clarus Therapeutics Holdings, Inc.fs12020_bluewateracq.htm

Exhibit 23.1

 

Independent Registered Public Accounting Firm’s Consent

 

We consent to the inclusion in this Registration Statement of Blue Water Acquisition Corp. (the “Company”) on Form S-1 of our report dated July 21, 2020, which includes an explanatory paragraph as to the Company’s ability to continue as a going concern, with respect to our audit of the financial statements of Blue Water Acquisition Corp. as of June 30, 2020 and for the period from May 22, 2020 (inception) through June 30, 2020, which report appears in the Prospectus, which is part of this Registration Statement. We also consent to the reference to our Firm under the heading “Experts” in such Prospectus.

 

/s/ Marcum llp

 

Marcum llp

New York, NY

September 2, 2020